This content is only available in German.
Dieser Inhalt ist nur auf Deutsch verfügbar.
0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
0900 712 713
(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
Notfallnummern
Hotline for child and youth emergencies
The Medgate Kids Line provides fast and simple medical advice when your child is unwell. The medical team from our partner Medgate is available by phone around the clock.
0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. by network operator)
0900 712 713
(3.13 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)
Please note: the Medgate Kids Line is currently offered in German.
Important Numbers
- 144 Ambulance
- 145 Tox Center (Poisoning)
- 117 Police
- 118 Fire Department
Kontakt Box
Our activities and studies
The focus of our activities is the competent supervision and execution of mono- and multicenter national and international clinical trials in collaboration with a local project leader at UKBB. We have expertise in the field of academic and industry-sponsored studies and are available to any discipline of the UKBB.
Click here to register or login www.clinicaltrials.gov
Click here to go to the website of the KIDS-STEP study: KIDS-STEP Study | UKBB
The following studies / projects are currently managed by us:
Anesthesiology
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
Midazoloam | Observational study to understand acceptability of various available midazolam formulations (syrup, rectal suppository, oro-dispersible minitablet) in clinical practice | Dr. med. Svetlana Beglinger | 70 | national, monocenter |
DATA STREAM
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
AI4HealthyCities Basel | PD Dr. med. Julia Bielicki | - | Data Science-Implementation hybrid | |
SwissPedHealth | Pediatric Personalized Research Network Switzerland (SwissPedHealth) – a Joint Pediatric National Data Stream | Luregn Schlapbach und Julia Vogt | - | national, multicenter |
SwissPedHealth
PREPP | SwissPedHealth Personalized Pediatric Primay care PREPP | Prof. Dr. med. Jan Bonhoeffer | - | national, multicenter |
Dermatology
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
AcneDect | Acne detection software | Prof.
Dr. med. Alexander Navarini | 40 (20 in
Basel) | National, multicenter |
Infectious Diseases
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
A randomised placebo-controlled
multi-centre effectiveness trial of adjunct betamethasone therapy in
hospitalised children with community acquired pneumonia (CAP) | Prof.
Dr. Johannes Van Den Anker | 700 (112 in Basel) | International, multicenter | |
ADEQUATE | Advanced Diagnostics for Enhanced Quality of Antibiotic Prescription in Respiratory Tract Infections in Emergency rooms | PD Dr. med. Julia Bielicki | 500 | International, multicenter |
Nephrologie
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
FIONA | A 6-month multicenter, randomized, double-blind,
placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age-and body
weight-adjusted oral finerenone regimen, in | Dr. med. Alexandra Goischke | 2 | International, multicenter |
FIONA OLE |
An 18-month,
open-label, single-arm safety extension study of an age-and bodyweightadjusted oral finerenone regimen, in addition to an ACEI or ARB,
for the treatment of children and young adults from 1 to 18 years of age
with chronic kidney disease and proteinuria | Dr. med. Alexandra Goischke | 2 | International, multicenter |
Infectious Diseases
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
Midazoloam | Observational study to understand acceptability of various available midazolam formulations (syrup, rectal suppository, oro-dispersible minitablet) in clinical practice | Dr. med. Svetlana Beglinger | 70 | National, multicenter |
PICSS | Post Intensiv Care Syndrome in Swiss Pediatric survivors and their Families | Prof. Dr. med. Daniel Trachsel | 60 | international, multicenter |
Neonatology
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
RoProp | Oral propanolol for the prevention of high-grade retinopathy of prematurity | Prof. Dr. med. Sven Schulzke |
| National, multicenter |
Neuropediatrics
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
PASTA | Paediatric Arteriopathy Steroid Aspirin High dose steroids in children with stroke and unilateral focal arteriopathy | Prof. Dr. med. Alexandre Datta | 24 (4 in Basel) | International, multicenter |
POOMAS | Prognosis, treatment, and mechanisms in an international paediatric onset opsoclonus myoclonus ataxia syndrome (POOMAS) database and virtual biobank | Prof. Dr. Andrea Klein | open register | International, multicenter |
SPHYNCS | Swiss Primary Hypersomnolence and
Narcolepsy Study | Prof. Dr. med. Alexandre Datta | (2-5 in Basel) | national, multicenter |
Oncology
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
SCCSS | Swiss
Childhood cancer Survivor Study-Follow up, Follow Up- Lungengesundheit nach
Krebs im Kindesalter | Prof. Dr. med. Nicolas von der Weid | 60-80 | National, Multicenter |
SwissPearl | Studie
zur Untersuchung der Lungenentwicklung bei Kindern u. Jugendlichen während und
nach Krebstherapie | Dr. med. Christina Schindera | 150 | National, multicenter |
Pediatric Phamacology
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
|
|
|
|
|
Rheumatologie
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
RHCG | Multicenter, open-label, efficacy, tolerability and pharmacokinetic study of
subcutaneous Ixekizumab with Adalimumab reference arm in children with juvenile
idiopathic arthritis subtypes of enthesitis- related arthritis (including
juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritis. | Dr. med. Andreas Wörner | 100 (5 in Basel) | International, multicenter |
Other disciplines
Studientitel | Principle Investigator | Total geplante Patienten | Design | |
|---|---|---|---|---|
|
|
|
|
|
Emergencies
0900 712 712
(3.23 CHF/min. CH-landline, possibly additionally 8 Rp. / min. by network operator)
0900 712 713
(3.12 CHF/min. prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)
Contact
University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland
T +41 61 704 12 12
Contact
About us
Legal Requirements
Emergency
Contact
University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland
T +41 61 704 12 12
Contact
© UKBB, 2024